Multiple myeloma patients receiving pre-emptive donor lymphocyte infusion after partial T-cell-depleted allogeneic stem cell transplantation show a long progression-free survival.

MLA

Levenga, H., et al. “Multiple Myeloma Patients Receiving Pre-Emptive Donor Lymphocyte Infusion after Partial T-Cell-Depleted Allogeneic Stem Cell Transplantation Show a Long Progression-Free Survival.” Bone Marrow Transplantation, vol. 40, no. 4, Aug. 2007, pp. 355–59. EBSCOhost, https://doi.org/10.1038/sj.bmt.1705742.

APA

Levenga, H., Levison-Keating, S., Schattenberg, A. V., Dolstra, H., Schaap, N., & Raymakers, R. A. (2007). Multiple myeloma patients receiving pre-emptive donor lymphocyte infusion after partial T-cell-depleted allogeneic stem cell transplantation show a long progression-free survival. Bone Marrow Transplantation, 40(4), 355–359. https://doi.org/10.1038/sj.bmt.1705742

Chicago

Levenga, H., S. Levison-Keating, A. V. Schattenberg, H. Dolstra, N. Schaap, and R. A. Raymakers. 2007. “Multiple Myeloma Patients Receiving Pre-Emptive Donor Lymphocyte Infusion after Partial T-Cell-Depleted Allogeneic Stem Cell Transplantation Show a Long Progression-Free Survival.” Bone Marrow Transplantation 40 (4): 355–59. doi:10.1038/sj.bmt.1705742.